Skip to main content
OpenTrials
Completed

NCT Number: NCT05645796

Improved Chest CT Diagnostic and Contrast Medium Administration

Investigation of impact of using different CM approaches on contrast enhancement in chest Ct examinations - A prospective study

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

OsloMet University

Oslo, 0130, Norway

About this study

Continuing advances in computed tomography (CT) in the past decades such as short scanning times with multi-detector CT (MDCT) requires contrast medium (CM) administration to be precisely planned to ensure a diagnostically accurate CT scans. To improve the chest CT diagnostic, the contrast enhancement in the thoracic vessels shoulde be increased.

The most important patient-related factors affecting the magnitude of vascular and parenchymal contrast enhancement are body weight. Historical practice has been to use a fixed volume of CM independent of body weight. Research has shown a clear relationship between vessel enhancement and patient weight, and that fixed CM volume technique is inappropriate, as smaller patients may receive excessive volume, and larger patients insufficient volume resulting in reduced image quality and poor diagnostic. In addition, excess CM can result in contrast induced adverse effects and nephropathy. To overcome these problems, it is essential to adjust the CM volume to the patient's total body weight and body composition. This adjustment can be done in different ways. The aim of this study is to identify which weight/body tailored CM administration is the best replacement for fixed CM administration in chest CT. The cost and procedure time will also be explored.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients undergoing chest CT examination between August 2019 and September 2021
  • age > 18 years

Exclusion criteria

  • hemodynamic instability
  • cardiac failure
  • pacemaker
  • renal insufficiency (estimated glomerular filtration rate <30 mL/min/1.73 m2)
  • contraindications to contrast enhanced CT
  • age < 18 years

Treatment and study plan

Adopted contrast media amount by using different approaches

Other

Using different contrast media approaches recommended by literature to explore the impact on the contrast enhancement in chest CT

Primary outcomes

  1. Contrast medium protocols in routine chest CT - A survey study

    Time frame: 15 months

    survey of what kind of contrast medium approaches are used in European hospitals

Sponsors and collaborators

Lead sponsor

Oslo Metropolitan University

Other

Collaborators

  • Oslo University Hospital

Registry information

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Dec 12, 2022
Registry last updated
Mar 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.